NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 29 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $11,000 | +37.5% | 5,000 | +11.1% | 0.00% | – |
| Q3 2019 | $8,000 | +14.3% | 4,500 | 0.0% | 0.00% | – |
| Q2 2019 | $7,000 | -30.0% | 4,500 | -10.0% | 0.00% | – |
| Q1 2019 | $10,000 | +11.1% | 5,000 | -24.2% | 0.00% | – |
| Q4 2018 | $9,000 | -40.0% | 6,600 | +8.2% | 0.00% | – |
| Q3 2018 | $15,000 | -46.4% | 6,100 | -7.6% | 0.00% | – |
| Q2 2018 | $28,000 | 0.0% | 6,600 | 0.0% | 0.00% | – |
| Q1 2018 | $28,000 | +27.3% | 6,600 | 0.0% | 0.00% | – |
| Q4 2017 | $22,000 | -18.5% | 6,600 | -7.0% | 0.00% | – |
| Q3 2017 | $27,000 | -12.9% | 7,100 | 0.0% | 0.00% | – |
| Q2 2017 | $31,000 | +19.2% | 7,100 | 0.0% | 0.00% | – |
| Q1 2017 | $26,000 | +36.8% | 7,100 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | -24.0% | 7,100 | -6.6% | 0.00% | – |
| Q3 2016 | $25,000 | 0.0% | 7,600 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | +13.6% | 7,600 | -15.6% | 0.00% | – |
| Q1 2016 | $22,000 | -29.0% | 9,000 | -5.3% | 0.00% | -100.0% |
| Q4 2015 | $31,000 | – | 9,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |